A novel antibiotic is under investigation for determination of safety margins. Concerns have been raised regarding potential hearing loss due to neurotoxicty. Based on early clinical trials, the median effective dose (ED50) is 10 mg/kg. Followup studies have found that median toxic dose (TD50) that is associated with hearing loss is 80 mg/kg. What is the therapeutic index for this novel antibiotic